Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Lonza
MedTech
Lonza to buy rapid microbial testing firm Redberry SAS
Swiss CDMO Lonza is making a move to strengthen and speed up quality control testing with the purchase of Redberry SAS.
Natalie Missakian
Oct 28, 2025 5:15am
Lonza's Synaffix inks ADC technology pact with Boehringer
Jan 9, 2025 8:00am
BigHat, Synaffix collab outfits AI science with ADC tech
Nov 4, 2024 11:07am
Lonza lands new CEO—Chutes & Ladders
Apr 5, 2024 8:30am
GSK loses R&D leader—Chutes & Ladders
Sep 22, 2023 9:30am
FDA sinks Allarity’s plans for lead oncology asset
Aug 2, 2022 2:41pm